Skip to content
value.today

Igenica Inc.

🇺🇸 Burlingame, California, USAPharmaceuticalsFounded 2008

Formerly Igenica Biopharmaceuticals, Inc.

Total raised
$52 M
6 rounds on record
Latest round
$2 M
Sep 2015
First round on record
Apr 2010
Today
Private
No later event on record

Funding rounds

6 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Igenica Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2015$2 MNo. 6$2 to $10 million

Igenica Inc.: Raise no. 6, Sep 2015

Investors in this round

10 investors had bought by the notice of Oct 14, 2015: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $5 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • John Celebi · Executive Officer
  • David Goeddel · Director
  • Gwen Fyfe · Director
  • John Diekman · Director
  • Mark Goldsmith · Director
  • Robert Schreiber · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Working capital and general corporate purposes.”

Signed by Michael Tenta, Secretary. Source: SEC Form D, newest notice filed Oct 14, 2015. Read the notice at the SEC.

equity, optionsSEC
May 2015$1 MNo. 5Under $2 million

Igenica Inc.: Raise no. 5, May 2015

Investors in this round

8 investors had bought by the notice of Jun 9, 2015: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $4 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • John Celebi · Executive Officer
  • David Goeddel · Director
  • Gwen Fyfe · Director
  • John Diekman · Director
  • Mark Goldsmith · Director
  • Robert Schreiber · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Working capital and general corporate purposes.”

Signed by Michael Tenta, Secretary. Source: SEC Form D, newest notice filed Jun 9, 2015. Read the notice at the SEC.

equity, optionsSEC
Jan 2015$5 MNo. 4$2 to $10 million

Igenica Inc.: Raise no. 4, Jan 2015

Investors in this round

10 investors had bought by the notice of Jan 26, 2015: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $6 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • John Celebi · Executive Officer
  • Carl Gordon · Director
  • David Goeddel · Director
  • Gwen Fyfe · Director
  • John Diekman · Director
  • Mark Goldsmith · Director
  • Robert Schreiber · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Working capital and general corporate purposes.”

Signed by Michael Tenta, Secretary. Source: SEC Form D, newest notice filed Jan 26, 2015. Read the notice at the SEC.

equity, optionsSEC
Jan 2014$7 MNo. 3$2 to $10 million

Igenica Inc.: Raise no. 3, Jan 2014

Investors in this round

7 investors had bought by the notice of Feb 7, 2014: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $14 M offered; $7 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • John A. Celebi · Executive Officer
  • Mary Haak-Frendscho · Executive Officer, Director
  • Carl Gordon · Director
  • David Goeddel · Director
  • Gwen A. Fyfe · Director
  • John Diekman · Director
  • Mark Goldsmith · Director
  • Robert Schreiber · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Working capital and general corporate purposes.”

Signed by Michael Tenta, Secretary. Source: SEC Form D, newest notice filed Feb 7, 2014. Read the notice at the SEC.

equity, optionsSEC
Jun 2012$20 MNo. 2$10 to $50 million

Igenica Inc.: Raise no. 2, Jun 2012

Investors in this round

8 investors had bought by the notice of Dec 4, 2012: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $33 M offered; $13 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • John Celebi · Executive Officer
  • Mary Haak-Frendscho · Executive Officer, Director
  • Carl Gordon · Director
  • David Goeddel · Director
  • John Diekman · Director
  • Mark Goldsmith · Director
  • Robert Schreiber · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael Tenta, Secretary. Source: SEC Form D and 1 amendment, newest notice filed Dec 4, 2012. Read the notice at the SEC.

equitySEC
Apr 2010$16 MNo. 1$10 to $50 million

Igenica Inc.: Raise no. 1, Apr 2010

Investors in this round

6 investors had bought by the notice of Sep 28, 2011: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$16 M of $24 M offered; $8 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Guoqing Chen · Executive Officer
  • Mike Rothe · Executive Officer, Director
  • Carl Gordon · Director
  • David Goeddel · Director
  • John Diekman · Director
  • Robert Schreiber · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for working capital.”

Signed by Michael Tenta, Secretary. Source: SEC Form D and 1 amendment, newest notice filed Sep 28, 2011. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Igenica Inc. chose not to state its revenue in its newest notice of a funding round (Oct 2015).

    SEC Form D · Oct 2015

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Oct 2015

That is all the official record says: Igenica Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Igenica Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 6 rounds above had up to 10 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Igenica Inc.
NameRoleNamed in
John CelebiExecutive officerOct 2015
John A. CelebiExecutive officerFeb 2014
Mary Haak-FrendschoExecutive officerFeb 2014
David GoeddelExecutive officerJun 2012
Guoqing ChenExecutive officerJun 2012
Mike RotheExecutive officerSep 2011
David GoeddelDirectorOct 2015
Gwen FyfeDirectorOct 2015
John DiekmanDirectorOct 2015
Mark GoldsmithDirectorOct 2015
Robert SchreiberDirectorOct 2015
Carl GordonDirectorJan 2015
Gwen A. FyfeDirectorFeb 2014
Mary Haak-FrendschoDirectorFeb 2014
Mike RotheDirectorSep 2011